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Since the first  demonstration by Feldmann and Basten  (1)  of B cell  triggering in 
vitro by T  cell-derived,  antigen-specific helper factor (Hf), 1 little  progress has been 
made in the cellular and molecular analysis of immune induction, largely because of 
technical difficulties.  Ideally, any such analysis requires  the testing of immunocom- 
petent  B cells  under conditions in which the minimally required set of cooperating 
elements  can  be  qualitatively  and  quantitatively  defined.  Several  years  ago,  we 
reported  (2-5)  on  the  in  vitro  conditions  for which  antigen-specific,  allogeneically 
restricted Hf triggers unprimed B cells  to generate primary IgM responses to soluble 
serum  proteins  and,  more recently, to histocompatibility antigens expressed  on the 
surface of chicken erythrocytes (CRBC).  We have further developed this system to 
the point where as few as 2,000 unprimed B cells  selected for immunocompetence to 
a  given histocompatibility haplotype by rosetting with  the appropriate CRBC gen- 
erate a powerful, Hf-dependent in vitro immunoglobulin M  (IgM) response. Because 
accessory (A) cells are limiting when such small numbers of B cells are used, we were 
able to demonstrate  (2)  an  absolute  requirement  for A  cells  in  successful  Hf-B cell 
interactions.  More importantly, such A cells  could be replaced by an A cell-derived, 
secretory product that  is not antigen specific.  In this communication, we report  on 
the further resolution of B cell triggering into functionally distinct steps, comparing 
both  Hf-mediated  and  lipopolysaccharide  (LPS)-induced  IgM  responses.  We  find 
that both Hfand LPS, in the presence of antigen but in the absence of A cells, trigger 
only B cell  proliferation. Hf- or LPS-induced IgM responses, however, are generated 
if A  cells  or  their  secreted  products  are  added  to  the  cultures.  These  A  cells  are 
radioresistant,  contain cells  that  bear Thy-1 antigen, and secrete their product in a 
manner  that  is  not  antigen  specific.  Further  experiments  showed  that  the  A  cell 
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requirement could be completely replaced by supernatant from an activated thymoma 
cell line, but only for the LPS-stimulated and not for the Hf-mediated B cell response. 
This  finding casts doubt on  the generally assumed  functional homology between  T 
cell-derived and  LPS-derived  triggering  signals.  In  addition,  it  has  recently  been 
reported  (6,  7)  that  antigen-specific T  cell help acts polyclonally on  B  cell blasts as 
opposed to small resting B  cells. Contrary to this claim, we have been able to show 
that immunocompetent B cells, regardless of their cell cycle state, respond to Hf in a 
manner that is antigen specific. 
Materials  and  Methods 
Animals.  CBA/J (H-2k), C3H/HeJ (H-2k), CBA/CAJ (H-Zk), BALB/cCr (H-2d), and C3H/ 
OH (H-2  °2) female mice were bred at Ellerslie Animal Farm, University of Alberta. Mice aged 
8-12 wk were used for cell cultures, and those aged 6-8 wk were used for the production of 
antigen-primed helper T  cells. CBA/J mice were routinely used for experiments, except where 
noted. 
Lines of chickens homozygous for the B 2 and B la major histocompatibility haplotypes were 
bred by the Biosciences Animal Services, University of Alberta. These lines of chickens represent 
original Hyline stocks that have been described previously in detail (8). 
Antigen.  CRBC  were  kept  in  Alsever's solution.  Before  use,  they  were  centrifuged  and 
depleted of buffy coat, washed three times with saline, and used as antigen either in culture or 
in the preparation of Hf (see below). 
Preparation of Antigen-primed T Cells.  In vivo antigen-primed T cells were obtained according 
to  the  method  of Hartmann  (9).  Briefly, mice  were  irradiated with  500  tad  (137Cs source, 
Gamma Cell 40 Irradiator, Atomic Energy of Canada Ltd., Ottawa, Ontario, Canada)  and 
injected intravenously with a  mixture of 15  ×  l0  s syngeneic thymocytes and 5 ×  107 CRBC 
suspended in Leibowitz (L-15)  medium  (Gibco Canada Limited, Calgary, Alberta, Canada). 
On day 7,  the animals were killed, and a  spleen cell suspension was prepared in Ca  *+- and 
Mg++-free phosphate-buffered saline (PBS). 
Preparation of Crude Extract from Carrier-primed T  Cells.  T  cell-derived helper  factor  was 
obtained as previously described (4, 5), with the modification that carrier-primed T  cells were 
suspended in Ca  ++- and Mg++-free PBS supplemented with  10  .4 M  EDTA. After spinning at 
400 g for 7.5 min, the cells were resuspended in ice-cold phosphate buffer (5 X  10 -2 M, pH 7.4) 
containing 10 .3 M EDTA at a concentration of 5 ×  107 cells/ml. Cells were homogenized in an 
ice-cooled glass-Teflon homogenizer for 20  min  at  a  speed of 80  rpm at  6 strokes per rain. 
Thereafter,  the homogenate was spun  at  35,000  g  for 30  min  and  the supernatant  used  for 
further purification of helper factor. 
Purification of T  Cell-derived Hf by Sephadex GIO0 Chromatography.  5  ml  of crude  factor in 
diluted saline was applied to a Sephadex G-100 column (1.5 ×  85 cm) that had previously been 
equilibrated with saline. Factor was eluted with saline at a flow rate of 17 ml/h and collected 
in fractions of 2.5 ml. During fractionation, absorbancy of the eluate was scanned at 280 nm. 
Fractions were pooled and concentrated as previously described (4,  5).  The second fraction 
(fraction  B)  was  concentrated  by  vacuum,  dialyzed against  saline,  and  passed  through  a 
Millipore filter (0.45 #; Millipore Corp., Bedford, Mass.). The filtrate was then  diluted with 
saline to a concentration equivalent to 500 ×  106 viable spleen cells/ml. This preparation was 
used in all experiments using Hf, unless otherwise stated. 
Preparation of Antigen Affinity-purified Hf by Column Chromatography.  Sepharose 4B beads (Phar- 
macia Fine Chemicals, Div. of Pharmacia Inc., Uppsala, Sweden) coupled (20)  with poly-L- 
lysine (Sigma Chemical Co., St. Louis, Mo.) were washed once in 9 x  10  .2 M  phosphate buffer 
(pH 7.4) containing 2.2 X  10  -1 M  sucrose. They were then mixed with thoroughly washed B2 
CRBC  in the same buffer at  a  ratio of 2 ml beads/0.5 ml of CRBC  (packed volume). The 
mixture was allowed to stand for 30  min  at  room temperature, after which glutaraldehyde 
(Fisher Scientific Co., Pittsburgh, Pa.) was added dropwise to a final concentration of 0.25%. 
During fixation with glutaradehyde, the mixture was gently stirred. After fixation at 37 ° for 90 
rain, the CRBC-coupled beads were washed three times in cold PBS and mixed with glycylgly- 250  B  CELL  STIMULATION BY  HELPER  FACTOR OR  LIPOPOLYSACCHARIDE 
cine (60 mg/100 ml of PBS), allowed to stand for 30 min at room temperature, washed in PBS, 
and  used  to  set  up  a  column  (0.9  X  3  cm).  The  column  was  washed  with  2  M  NaCI  and 
buffered with PBS. A  preparation  of crude extract from B2-primed T  cells was applied to the 
column at a  flow rate of ~6 ml/h. After washing with PBS (five column volumes), 2 M  NaC1 
(three column volumes) was added for elution of bound material. Both the bound material that 
had been eluted and unbound  (pass-through)  material were concentrated by vacuum filtration, 
dialyzed  extensively against  PBS  (Dulbecco),  and  passed  through  a  Millipor  filter  (0.45  ~t; 
Millipore Corp.). The filtrate was then diluted with PBS to a concentration equivalent to 500 
X  10"viable spleen cells/ml. 
Preparation of Rosette-forming Cells (RFC)  and Nonrosette-forming Cells (NRFC).  RFC  were 
prepared according to a modification of the method of McConnell et al. (10).  Briefly, unprimed 
mouse spleen  cells in  Dulbecco's  PBS  supplemented  with  5%  fetal calf serum  (FCS;  Gibco 
Canada Limited, Calgary, Alberta, Canada)  were fractionated by means of an Isopaque-Ficoll 
(Pharmacia  Fine Chemicals  Inc.,  Uppsala,  Sweden)  gradient  spun  at  2,000  g  for 30  min  at 
20°C.  After washing,  a  suspension  of  108  cells/ml was  taken  from  the  middle  layer  of the 
gradient and mixed with 5 X  107 CRBC/ml of cell suspension and kept at 4°C for a minimum 
of 60 rain. The mixture was then separated on an Isopaque-Ficoll gradient, as above. Using this 
5  5  8  method,  the pellet yielded, along with CRBC, ~2 X  10  to 4  ×  10  RFC per  10  middle layer 
spleen cells. Over 90% of these RFC were surface immunoglobulin positive, and anti-Thy-l.2 
and C' treatment  of spleen does not affect the yield of RFC (unpublished  observations).  The 
pellet was washed three times before use as a source of RFC with PBS containing 5% FCS. The 
remaining nonrosetted cells were irradiated with 1,500 tad and were washed three times in PBS 
containing  5%  FCS before use as a  source of A  cells at  a  concentration  of 2  X  106 cells per 
culture. 
Tissue Culture.  RFC were cultured in triplicate at a concentration of 2 ×  103 RFC in 0.2 ml 
of Click's culture medium (11)  containing 10% Rehatuin FCS (Reheis Chemical Co., Chicago, 
Ill.)  in  Linbro  microculture  plates  (Flow  Laboratories,  Rockville,  Md.)  and  placed  in  an 
incubator gassed with  10% CO2 in air. 2-mercaptoethanol at a  final concentration of 5 ×  10 .8 
M  was added to all cultures. 
Adherent Cells.  A suspension of 8 x  107 spleen cells in 8 ml of complete Click's medium was 
incubated  at  37°C  in  100  ×  20-mm  tissue  culture  dishes  (Corning  Glass  Works,  Science 
Products  Div., Corning,  N.  Y.).  After  1  I/2  h,  the  adherent  cells were  gently resuspended, 
transferred to new dishes, and incubated for an additional  1 h. The same process was repeated 
once more, and adherent cells were harvested using a  rubber policeman, then irradiated  with 
1,500  rad and washed before use in culture. 
Adherent Cell  Supernatant.  Irradiated  adherent  spleen  cells  were  cultured  for  3  d  at  a 
concentration  of 2  ×  106 cells/ml in  10 ml of Click's medium  in  100  ×  20-mm  tissue culture 
dishes.  Cultures  were  maintained  in  a  10%  CO2  in  an  air  atmosphere  at  37°C.  Culture 
supernatants  were collected and passed through 0.45-/~ Millipore filters. The concentration of 
supernatant  is expressed in terms of volume-equivalents per  108 viable cells from which it was 
obtained. 
Anti-Thy-l.2 Treatment.  Monoclonal anti-Thy- 1.2 antibody was obtained from New England 
Nuclear, Lachine, Quebec. The method used was that  of Shaw et al.  (12,  13).  Briefly, spleen 
cells were suspended at 2 X  107 cells/ml in antibody reconstituted with medium or in medium 
alone (Leibovitz +  0.1% gelatin) and  incubated  at 37 °  for 20 rain, after which the cells were 
pelleted  and  resuspended  in  the  original  volume,  using  absorbed  rabbit  complement  (C') 
diluted  1/5  in  medium.  After 45-min  incubation  at  37 °, cells were pelleted, resuspended  in 
culture  medium,  and  the  viability  after  treatment  was  determined  by  eosin  dye  exclusion. 
Treated cells were always used in numbers equivalent to the untreated control to avoid selective 
enrichment of the remaining cells. 
IL-2.  Partially  purified supernatant  from an  IL-2-secreting T  lymphoma  line  (EL4)  was 
kindly provided by Dr. V. Paetkau and B. Caplan,  Department of Biochemistry, University of 
Alberta. This cell line, obtained  from Dr. J. Farrar  (National  Institutes of Health,  Bethesda, 
Md.) has been described in detail (14).  The amount of IL-2 in the supernatant  was quantitated 
in the T  cell growth factor assay of Gillis (15). 
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of 10/Lg/ml of culture medium. The concentration used for the generation of B cell blasts was 
10 ~g/ml. 
Antibody-forming Cells (AFC).  The number of AFC was determined by the direct hemolytic 
plaque assay of Cunningham (16). CRBC of the appropriate haplotype were used as targets at 
a  final  concentration of 1.5  ×  108 cells/ml in Mishell-Dutton's balanced salt solution  (17). 
Immune responses were expressed in terms of AFC/culture. 
Cell Proliferation.  The degree of cell proliferation was measured in a Beckman scintillation 
counter (Beckman Instruments, Inc. Fullerton  Calif.)  after an  18-h pulse with  5 /~Ci/ml  of 
[aH]thymidine  (2  Ci/mmol)  (Amersham Radiochemicals,  Oakville,  Canada).  Results  were 
expressed as counts per minute per culture and measurements carried out on day 4 of culture, 
unless stated otherwise. 
Antibodies.  Monoclonal anti-I-A  K  (K,¥ 2b) (116-32) antibody was kindly provided by Dr. G. 
H~mmerling, Department of Genetics, Universit~  of Cologne. The serological properties of this 
antibody  have  been  described  (18). Anti-H-2  antibody  was  kindly  provided  by  Dr.  T. 
Wegmann  from  this  department.  The  serological  properties  of this  antibody  have  been 
previously described  (19). Rabbit anti-mouse IgG antibody was purchased from N. L. Cappel 
Laboratories, Inc., Cochranville, Pa. Antibodies were coupled (20) to Sephadex 4B beads, and 
putative Hf was absorbed by the batch method. 
Results 
Results of the IgM Response into Proliferative and Differentiative Events.  We demonstrated 
that  the initiation  of a  specific in  vitro IgM response by unprimed  murine  B  cells 
requires  three components--antigen,  antigen-specific T  helper cells, and A  cells,  in 
the  form of irradiated  NRFC  or  adherent  cells--and  that  the  requirement  for T 
helper cells and A  cells can be replaced by products extracted  from or secreted by 
these two cell classes, respectively (2).  In view of the conflicting reports regarding the 
nature of signals provided to B cells by antigen  (21-23), helper T  cells (22,  24), and 
A cells (7, 25, 26), we performed reconstitution experiments in which B cell prolifer- 
ation and differentiation were measured in response to antigen and T  cell-derived Hf, 
with or without A cell culture supernatant. 2 ×  103 unprimed spleen cells, specifically 
enriched by rosetting with CRBC of the B 2 MHC haplotype, were cultured with B ~ 
CRBC  alone  (B  2  RFC)  or  with  the  addition  of B2-specific  Hf or  A  cell  culture 
supernatant,  or  with  both.  Results  show  that  immunocompetent  B  cells  neither 
proliferate  nor  differentiate  into  AFC  in  the  presence  of antigen  alone  (Table  I). 
However,  in  the  presence  of Hf and  antigen  but  in  the  absence  of A  cell  culture 
supernatant, a proliferative response is observed; in spite of this proliferative response, 
few AFC  are generated.  Neither cell  division nor differentiation  is observed in  the 
presence of antigen and A cell supernatant.  Full reconstitution of the AFC response 
requires signals derived from both antigen-specific Hf and A cell culture supernatants. 
This AFC response is specific for B 2 RFC but shows a  low degree of cross-reactivity 
with B la RFC, as previously discussed (2). 
Parallel experiments using LPS as a nonspecific activator rather than Hf were also 
performed. In the presence of LPS but in the absence of A cell culture supernatant, 
B cells enriched  for responsiveness to the B 2 CRBC antigen undergo marked prolif- 
eration.  Despite intense  cell  division,  no significant  degree of B  cell  differentiation 
into AFC is observed unless cultures are provided with both LPS and A cell culture 
supernatant. This AFC response, unlike that seen with Hf, is not specific for B ~ RFC. 
We  examined  the  specificity of the  proliferative  response  using  Hf purified  by 
antigen-affinity column chromatography. B 2 or B 13 RFC were cultured alone or with 
various concentrations  of affinity-bound or unbound  Hf B ~ (Fig.  1).  Results  show 252  B  CELL  STIMULATION  BY  HELPER  FACTOR  OR  LIPOPOLYSACCHARIDE 
TABLE  I 
Separation  of the IgM Response into Proliferative and Differentiative Events 
Adherent cell  [aH]thymidine uptake  AFC/culture* ~ ±  RFC  Hfor LPS  supernatant  (cpm) ~ ±  SEM  SEM 
B ~  --  -  317 +  82~:  <I 
B 2  HfB 2  -  12,307 ±  825  43 ±  13 
B 2  --  +  282 _  64  <1 
B e  HfB 2  +  10,072 ±  832  408:1:124 
B 1'~  HfB 2  +  ND§  72 ±  20 
B 2  --  -  415 ±  35  <1 
B 2  LPS  -  63,115 ±  1,831  44 2:18 
B 2  --  +  440 ±  35  <1 
B 2  LPS  +  59,049 +  669  432 ±  30 
B ~a  LPS  +  ND  398 ±  45 
2 X  103 RFC were cultured in the presence or absence of 5  X  l0  s cell equivalents Hf, or  10 #g/ml LPS, 
and/or 2 X  104 cell equivalents of adherent cell supernatant for 4 d, [aH]thymidine uptake and numbers 
of AFC were counted on day 4. 
Note:  Hf or LPS, in the absence of A cell supernatant, induce RFC proliferation;  the addition of A cell 
supernatant  promotes differentiation  into  AFC.  B 2 Hf-induced differentiation  is specific for  B 2 RFC, 
whereas LPS-induced differentiation is not. 
* AFC produed by B 2 RFC were assayed on B 2 target CRBC; those produced by B ~3 RFC were assayed on 
B ~a CRBC. 
~: Control [aH]thymidine uptake by 2 X  10  a Thy-l.2 and A-cell depleted spleen cells equals 331  +  14. 
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FIG.  1.  Proliferative  activity of affinity-purified Hf.  2  X  103  B ~ (O)  or  B za (0)  RFC  were  cul- 
tured for 4 d with various concentrations of B 2 affinity-column purified Hf (expressed in equivalents 
of 1 ×  10  s helper T  cells from which it was extracted).  Results are expressed as means -  SEM of 
[aH]thymidine uptake on day 4 of culture. (A), bound Hf B2;  (B), unbound Hf B 2. 
that  the proliferative  activity  of affinity-bound  Hf  is antigen  specific.  Although  there 
is some  stimulation  of B la RFC  with  both  bound  and  unbound  Hf  B 2,  an  additional 
B2-specific proliferative  component  can  clearly  be demonstrated  using  affinity-bound 
HfB 2 with  B ~ RFC. 
Resting  B  Cells  and  B  Cell  Blasts  Are  Triggered  Antigen-specifically  by  Hf  Antigen- 
specific  T  cell  help  for  resting  B  cells  has  been  reported  to  polyclonally  stimulate  B 
cell  blasts  (6,  7).  We  examined  this observation  using  either  LPS-treated  or untreated 
B  cells,  both  of  which  were  enriched  for  responsiveness  to  B 2  CRBC  (Table  II). M.  A. JAWORSKI, C.  SHIOZAWA, AND  E.  DIENER 
TABLE II 
Unprimed and 48-h LPS-primed B Cells Depend on Antigen-specific Hf  for Immune Trz~egering 
253 
Contents of culture 
RFC  Hf  NRFC 
AFC/culture ~ ±  SEM 
Unprimed cells  LPS primed blasts 
B 13  B la  B 13  300 ±  54  296 ±  14 
B la  B 2  B ~a  86 ±  12  62 ±  13 
B 2  B 2  B 2  373 ±  20  292 ±  20 
B 2  B la  B ~  80±37  36±  15 
Unprimed B cells;  2 ×  10  a RFC were cultured with 2 ×  106 irradiated NRFC for 4 d  in the presence of 5 
×  10  ~ cell  equivalents of B la- or B2-specific  Hf. LPS-primed B cells;  2 ×  10  a RFC were cultured with  10 
#g/ml of LPS for 48 h, washed, and recuhured for an additional 48 h with 5 X  10  ~ cell equivalents of ffa 
or B2-specifie  Hr. Both groups were assayed on day 4 of cuhure. 
PFC/CULTURE 
5 
Hf  RFC  nonRFC  t  (  ( 
+ 
-+ 
Fro.  2.  Allogeneic restriction by H-2 controls Hf-B cell  cooperation and is enhanced by A cells. 
Note that non-H-2 strain differences have no influence on Hf-B cell cooperation. 
Results  show  that  both  LPS-induced  B  cell  blasts  as  well  as  resting  B  cells  are 
optimally triggered to produce AFC only in the presence of Hf of appropriate antigen 
specificity. We conclude that activated B cell blasts are no different from unstimulated 
B cells in their response to antigen-specific Hf. 
Major Histocompatibility  Complex (MHC) Control of the IgM Response Involves Hf B Cells, 
and A  Cells.  In an  earlier  publication  (3),  we demonstrated  the  existence  of MHC 
restriction at the level of Hf-B cell cooperation. In view of previous and current studies 
on the definition of a  minimal set of cooperating elements in B cell triggering, we felt 
it important  to determine the extent to which A  cells are involved in mechanisms of 
allogeneically restricted Hf-B cell interaction. Accordingly, reconstitution experiments 
were set up, consisting of different syngeneic and allogeneic combinations of antigen- 
specific HI', B cells, and A  cells together with the appropriate antigen. We found that 254  B CELL STIMULATION BY HELPER  FACTOR  OR LIPOPOLYSACCHARIDE 
TABLE III 
Hf ls Absorbed by Anti-IA k, but Not by Anti-H-2 d or Anti-IgG Antiserum 
Hf absorbed by  AFC/culture  (± SEM)* 
Sepharose 4B  248 ± 20 
Anti-IAk-Sepharose 4B  12 ±  18 
Anti-H-2a-Sepharose 4B  156 ~ 32 
Anti-IgG-Sepharose  4B  260 ztz 25 
2 ×  10  a RFC and 2 ×  106 NRFC from CBA/J mice were cultured for 4 d in the presence of 5 ×  t06 cell 
equivalents of Hf B z that had previously been absorbed on sepharose alone, or sepharose coupled to anti- 
IA  k, anti-H-2  a, or anti-lgG antibody. 
* Assayed on B  2 CRBC. 
full  immunocompetence  is  observed only when  Hf and  B  cells  are  H-2 compatible 
(Fig.  2),  in which case cooperation between  Hf and  B  cells in the  presence of either 
syngeneic or allogeneic A  cells  is equally efficient.  However, although an allogeneic 
combination of Hf and B cells reduces responsiveness by ~70%, incompatibility of Hf 
with both B cells and A cells entirely abolishes the AFC response. This finding agrees 
in principle with the original observation of allogeneic restriction between cooperating 
T  and  B  cells  (27)  and  furthermore  designates  the  A  cell  as  part  of its  underlying 
mechanism. 
In view of this and the data described above, we decided to look for the presence of 
I-A  subregion-encoded  determinants  on  Hf  (Table  III).  As  indicated  by  affinity 
chromatography  using  monoclonal  anti-I-A  k  antibody,  Hf contains  these  determi- 
nants, whereas conventionally raised anti-H-2 d and anti-IgG antibody fail to bind Hf. 
From these results,  we conclude that  allogeneic restriction  of the IgM response in 
vitro  involves  Hf and  B  cells  as  well  as  A  cells.  The  role  of I-A-encoded products 
present on our Hf in this collaborative response remains undefined. 
Anti-Thy-l.2  Treatment  Abrogates  A  Cell  Function  in  the  Hf  or  LPS-mediated  AFC 
Response.  There has been conflicting evidence concerning the requirement  for T  cells 
as  accessory  cells,  both  for  Hf-mediated  (24,  28)  and  for  LPS-induced  (29-32) 
antibody responses. 
In previous experiments, we reported (2) that spleen cells treated with conventional 
anti-Thy-1.2 anti-serum and C' were as responsive to Hf-mediated immune triggering 
as  normal  spleen  cells.  In  our  search  for  the  identity  of the  A  cell  capable  of 
reconstituting  the  AFC  response,  as  previously  described  (2),  we  have  reexamined 
these earlier  data, .using experimental  conditions  in which T  cells are  more likely to 
be present in limiting numbers and using monoclonal high titer anti-Thy-1.2 antibody 
for the depletion of participating cell populations. 
Under these more stringent conditions, differentiation  after Hf- or LPS-induced B 
cell  proliferation  depends  on  the  presence  of a  radioresistant,  Thy-l.2-positive  cell 
found in the NRFC population.  Thus, anti-Thy-l.2 and C' treatment  of A  cells used 
to reconstitute  Hf- or LPS-stimulated  B cell cultures resulted  in a  80-90% reduction 
in numbers of AFC compared to those of control cultures  (Table IV). Anti-Thy-1.2 
and  C'  treatment  of RFC  did  not  affect  their  immunocompetence  because  such 
treated cells respond well in the presence of A  cells treated with C' only. 
These  results  indicate  that  Thy-l.2-bearing  cells  must  be  present  in  the  A  cell 
population to facilitate Hf- or LPS-induced antibody production. M.  A. JAWORSKI,  C.  SHIOZAWA, AND  E.  DIENER  255 
TABLE  IV 
Anti-Thy-l.2  Treatment Abrogates A  Cell Participation  in the Hf- or LPS-mediated  IgM Response 
Contents of culture  AFC/cuhure (.~ +  SEM) 
RFC  NRFC  H f B  1~  LPS 
C'  C'  540 ±  129  1,244 ±  84 
a Thy-l.2 + C'  C'  497 ±  12  1,080 ±  108 
C'  a Thy-l.2 + C'  72 +  11  160:1:68 
a Thy-l.2 +  C'  a Thy-l.2 + C'  58 ±  27  75 ±  32 
Unprimed spleen  cells were  treated with C' or anti-Thy-l.2 plus C', incubated with B la CRBC, then 
fractionated into RFC and NRFC. RFC yield was unaffected by anti-Thy-l.2 plus C' treatment. 2 ×  103 
RFC were cultured with 2 ×  10  e C' treated NRFC or the equivalent number of cells remaining after anti- 
Thy- 1.2 plus C' treatment, and 5 X 10  ~ cell equivalents of Hf or 10 #g/ml of LPS. AFC were measured on 
day 4. 
TABLE  V 
Supernatant from an Activated  Thymoma  Cell Line  (EL4) Replaces the Requirement for Accessory Cells in 
the LPS-induced  but Not in the Hf-mediated  IgM Response 
RFC 
Concentration of  AFC/cuhure (g ±  SEM) 
IL-2 on EL4 
supernatant  No Hf or LPS  Hf B In  LPS 
B t3  --  ~1  ~1  ~1 
B ta  1  :  20,000  < 1  <~ 1  < 1 
B  ~3  1:6,000  <: 1  < 1  50 ±  27 
B ~a  1:2,000  < 1  < 1  84 --. 36 
B  ~3  1:600  <1  <1  224 ±  34 
B ~3  1:200  <1  <1  228 ±  16 
B ~a  1:60  <1  <1  396+ 9 
B j3 anti-Thy-  1.2 + C'  1:60  < 1  < 1  360 ±  51 * 
B ~s C'  1:60  <1  <1  340 ±  76* 
B  '3  NRFC  14 ±  5:~  296 +  64:]:  356 ±  27:1: 
2 ×  103 RFC were cultured for 4 d in the presence or absence of 5 ×  10  e cell equivalents of Hf or of 10 
#g/ml LPS, and with varying concentrations of purified supernatant from an IL-2 producing cell line. 
Concentrations of IL-2  in the supernatant are expressed  in  terms of activity in a standard thymocyte 
proliferation assay for IL-2, where a  1:200 dilution gives maximum thymocyte proliferation. 
* Spleen cells were preincubated with C' or with anti-Thy-I.2 antibody and C', washed, incubated with 
B l:~ CRBC, and fractionated into RFC and NRFC. 
:~ Control cultures containing 2 ×  10  a RFC and 2 ×  10  n NRFC alone or with Hfor LPS. 
Supernatant from an Activated,  IL-2-secreting  T  Lymphoma  Cell Line Replaces A  Cells in the 
LPSoinduced but Not the Hf-mediated IgM Response.  Having demonstrated a  requirement 
for Thy-l.2-bearing,  radioresistant and  nonantigen-specific A  cells in  the  LPS-  and 
Hf-induced IgM response, we explored the possibility that the culture supernatant of 
such  cells  might  be  identical  with  IL-2.  This  T  cell-derived lymphokine  has  been 
shown (33,  34)  to support an antibody response to heterologous erythrocyte antigens 
by  spleen  cells  from  nu/nu  mice.  In  our  experiments,  partially  purified  culture 
supernatant  from an  IL-2-secreting T  lymphoma  (EL4)  was substituted for A  cells. 
EL4  supernatant  in  the  absence  of Hf  or  LPS  fails  to  stimulate  AFC  production 
(Table V).  However, in the presence of LPS, the supernatant  reconstitutes the AFC 
response in a  dose-dependent fashion; at  appropriate concentrations, the response is 
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The optimal  concentration  of supernatant  required  for reconstitution  of the  LPS 
response is comparable to that needed for maximum proliferation of thymocytes in a 
standard  assay  for  IL-2  (15).  Therefore,  to  investigate  the  possibility  that  EL4 
supernatant might be acting via a small number of contaminating T  cells in the RFC 
population, the latter were depleted of putative Thy-1.2-bearing ceils before culture. 
The results show that the capacity of EL4 supernatant  to generate AFC  from LPS- 
stimulated B cells is independent of Thy-l.2-positive cells.  Supernatant  from which 
colony stimulating  factor  (CSF),  which  is  coproduced  by  the  cell  line,  had  been 
removed by ion-exchange and  phenyl-sepharose chromatography did  not  affect its 
reconstituting potency for AFC production (data not shown). 
In  marked  contrast  to  its  effect  on  LPS-stimulated  B  cell  cultures,  the  EL4 
supernatant, when tested over a  wide range of concentrations (including those that 
were effective in  triggering the  LPS-mediated response),  failed to  promote an  Hf- 
induced AFC  response.  Control cultures using NRFC  instead  of supernatant  were 
readily reconstituted, indicating the functional integrity of the Hf used in the above 
experiment. We conclude that the triggering of B cells into AFC by antigen-specific 
Hfrequires A cells that are either different from or supplementary to those needed for 
AFC responses induced by the polyclonal activator LPS. 
Discussion 
The purpose of this study was to arrive at a definition of the cellular and molecular 
requirements for Hf-mediated and LPS-induced (for purposes of comparison) B cell 
proliferation and differentiation into AFC. 
This has been made possible by culturing B cells specific for a  given antigen  in 
numbers small enough to limit the participation of accessory cells and to reduce the 
background activity to an average of< 1 AFC per culture. The stepwise reconstitution 
of such B cell cultures with other cooperative elements in either soluble or cellular 
form  has  permitted  the  dissection  of the  IgM  response  by  B  lymphocytes into  a 
proliferative and differentiative event, each of these depending on a distinct triggering 
signal. 
Of considerable interest  in  this respect  is whether or not  the immunocompetent 
cell's triggering mechanism  is measurably affected by antigen binding alone in the 
absence of Hf and  A  cells.  B  cell proliferative responses induced by antigen  alone 
have  been  described  in  several  reports  (21,  23).  In  agreement  with  others  (22), 
however,  we  found  no  evidence  that  antigen  alone  induces  B  cells  to  undergo 
proliferation. Our data show that RFC in the presence of antigen and Hf but in the 
absence of A cells undergo proliferation with little differentiation into AFC. Using Hf 
purified  by  affinity  chromatography,  both  an  antigen-specific  component  and  a 
nonantigen-specific  component  could  be  demonstrated  for  this  proliferation;  B ~- 
specific Hf was shown to induce a proliferative response with B13-specific RFC, which 
was of significantly lower magnitude than with BX-specific RFC. This is in the same 
range as the functional specificity of our Hf with regard to antibody formation, when 
the  Hf is  reconstituted  with  A  cell  products  (2).  It  is  possible  that  the  unbound 
material inducing nonspecific proliferation might be due to a contaminant of the Hf 
preparation superimposing its effect on an antigen-specific, Hf-dependent proliferative 
signal.  Such  an  explanation  includes  the  possibility  that  nonspecifically  induced 
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the dissociation of an antigen-specific molecular complex whose stability in vitro is 
short-lived. 
We previously showed (2) that the A cells required to reconstitute an Hf-dependent 
IgM response are adherent,  radioresistant,  and not antigen specific in their activity. 
We now extend these findings to demonstrate that A cells secrete a product(s) that, in 
the  presence of Hf and Ag, can  trigger the  differentiation  of immunocompetent B 
cells into AFC.  In the absence of Hf, however, the A  cells or their products have no 
effect on B  cells. This is compatible with  the suggestion that  B cells might become 
receptive to nonspecific differentiative signals at some point during the course of an 
antigen-specific response (25, 35). 
In our previous work  (2),  using conventionally prepared anti-theta serum rather 
than monoclonal Thy-1.2 antibody, this treatment of spleen cells did not affect their 
response to Hf. In this study, using monoclonal antibody and an irradiated population 
of A cells, we demonstrate that the latter must contain Thy-l.2-bearing cells. These 
new findings suggest that at least one of the classes responsible for the reconstituting 
effect of the A  cell  population  might  bear a  low density of Thy-l.2 antigen  (thus, 
being relatively insensitive to killing by conventional serological means) or that these 
cells can exert  their  biologic effect even when  present  in  very low numbers.  These 
data are also compatible in principle with reports by other investigators (24,  35-39) 
who have described the collaboration between different classes of helper T  cells that 
are readily distinguishable by a number of criteria. In one such model, one class of T 
cells releases an antigen-specific signal  that  leads  to  B  cell proliferation,  whereas a 
second type of T  cell releases nonantigen-specific factors that  promote B cell differ- 
entiation  (35).  Another  group  of investigators  (37,  38)  has  described  cooperation 
between two distinct classes of T  cells in the secondary humoral response; one of the 
participating T  cell classes is an adherent  cell whose mode of action  appears to be 
polyclonal. 
The question of how Thy-1.2-negative A cells are contributing to B cell differentia- 
tion is currently under investigation. The requirement  for macrophages in Hf-medi- 
ated responses has been reported (40).  It is, in this context, worth remembering that 
T  cells or their products  have been  shown  to activate macrophages  (41),  and  it  is 
possible that our data reflect the necessity for a T  cell to provide such a macrophage- 
activating  factor.  Experiments  using  cultured  bone  marrow-derived  macrophages, 
whose cooperative potential requires a mitogen-activated T  cell, as a source of A cells 
are currently underway. 
For comparison, we also analyzed the in vitro immune response to rosette-forming 
B cells, using the polyclonal activator LPS, again under conditions in which A  cells 
are limiting. As with Hf, LPS induced only B cell proliferation in these cultures. It is 
difficult  to  reconcile  this  result  with  reports  that  LPS  by itself induces  B  cells  to 
differentiate into AFC. Our LPS-stimulated cultures had to be reconstituted with A 
cells or their culture supernatant to observe direct plaque-forming cells; it is important 
to  note  that  no  differentiation  into  AFC  was  observed  with  A  cells  or  A  cell 
supernatant  alone  in  the  absence  of LPS.  The  finding  that  depletion  of Thy-l.2- 
bearing cells results in the ablation of the LPS-dependent IgM response is in contrast 
to the reported T  independence of this response (31,  32).  However, our findings agree 
with  those of other  investigators  (29,  30),  who have shown  that  under  appropriate 
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response.  It is probable, therefore, that  these cells have also become limiting in our 
RFC population under the culture condition we used, thereby unmasking the T  cell 
dependence of this response. 
The parallels between the proliferative response induced by both Hf and LPS and 
the requirement  in both cases for A cells (including Thy-l.2-bearing cells)  to recon- 
stitute the IgM response might initially suggest that they deliver signals to B cells via 
similar pathways, rendering them receptive to the same differentiative signal derived 
from A cells or their supernatant.  This is most likely incorrect, however, as demon- 
strated by our attempt to replace A cells with purified supernatant  derived from an 
IL-2-secreting T  lymphoma cell line (EL4). The reconstitution  from a  merely prolif- 
erative to a  fully differentiated  IgM response occurred only in  the presence of LPS 
but not of Hf. This strongly suggests that the Hf-mediated response has either different 
or additional  A  cell requirements and  indicates  that  IL-2, at  least  by itself, cannot 
provide the A cell signal for Hf-primed B cells. 
Among its spectrum of activities, II-2 has been described to restore the anti-SRBC 
antibody response by spleen cells of nude mice (33,  34)  and to act synergistically with 
macrophages  in  promoting  B  cell  differentiation  (25).  In  our  system,  also,  the 
magnitude of the IgM response was directly proportional to the concentration of IL- 
2 in the EL4 supernatant.  We note, however, that by itself, EL4 supernatant  could 
not induce the differentiation of B cells into IgM-secreting cells; its activity required 
the  presence of LPS, which  induced  B cell proliferation. As discussed  by Delovitch 
(42),  IL-2,  like  the  TRF  of Schimpl  and  Wecker  (21)  might  belong  to  a  class  of 
lymphokines that can enhance antibody secretion by previously activated B cells. In 
addition,  preliminary experiments show that  the activity of the EL4 supernatant  is 
absorbed out by activated T  cells, which is one of the properties of IL-2 (43). 
Although the above data on the LPS-induced response agree with the notion that 
the reconstitution of the A cell signal could be mediated by IL-2, we are nevertheless 
exploring the possibility that  our findings  might  be due to some other lymphokine 
concomitantly secreted by the tumor, such  as the TRF described by Schimple and 
Wecker (21).  In this regard, we point out that  the differentiation of LPS blasts into 
IgM-secreting cells in the presence of EL4 supernatant was not affected by anti-Thy- 
1.2 and C' treatment of the responder RFC population. This suggests that the active 
component  in  the  supernatant  could  be acting  directly  on  the  B  cells  rather  than 
indirectly inducing T  cells to generate a  B cell differentiation factor. 
It has recently been proposed (6,  7)  that antigen-specific T  cell help, while acting 
specifically on resting B cells, stimulates B cell blasts polyclonally, regardless of their 
antigen specificity. Using our antigen-specific, T  cell-derived Hf, we cannot confirm 
this finding.  In our system, the generation  of the IgM response by B cell blasts still 
depends on the  presence of Hf of the appropriate antigen  specificity, as is  the case 
with cultures containing resting B cells. This indicates that transformation of a B cell 
into  the  blast  state  is  not  sufficient  to  make  it  susceptible  to  nonantigen-specific 
triggering by Hf, and we conclude that the phenomena observed by Schreier and co- 
workers (6,  7) are not mediated by our Hi'. 
In our opinion, this descrepancy and others between our findings and those of the 
above investigators might  be due  to  differences  in  methodology.  Among these,  we 
mention our use of affinity-enriched B cell cultures so that only 2 ×  103 cells, with no 
requirement  for  additional  filler  cells,  can  mount  a  strong  IgM  response  when M.  A. JAWORSKI, C.  SHIOZAWA, AND E.  DIENER  259 
stimulated  by appropriate  factors.  Another  difference arises  from  the  difficulty  in 
determining which classes of cells are elaborating the various factors produced in their 
system (6,  7). It is thus possible that the characteristics attributed  to antigen-specific 
T  cell help (6,  7, 22, 44) might be due in part to the generation of nonspecific T  cell 
factors as well as factors arising from sources other than T  cells.  In this  regard, we 
stress that our current experiments using Hf, which is secreted by long-term cultured 
helper T  cell lines without the use of filler cells and then purified by affinity-column 
chromatography, have so far yielded results that are similar to those reported here for 
Hf obtained  by extraction  (manuscript  in  preparation).  It  is  also  hoped  that  the 
approach of using better characterized factors, such as IL-1 or IL-2, in the place of 
various supernatant  preparations will clarify some of the above-mentioned ambigui- 
ties. 
We have previously shown (3) that Hf is allogeneically restricted in its cooperation 
with B cells. This restriction is controlled by the MHC region, and we are currently 
mapping  it  to  specific  MHC  subregions.  The  requirement  for  histocompatibility 
between  Hf and B cells for optimal interaction  agrees with the concept of I-region- 
controlled  allogeneic  restriction  between  cooperating  T  and  B  cells  (27).  It  is  also 
compatible with the serological evidence by ourselves and others (45) for the presence 
of I-A determinants  on  HE  Whether  or not  this  determinant  is  identical  with  the 
interaction  site for a  corresponding B  cell surface receptor remains speculative.  We 
observe that, although allogeneic restriction is present when there is incompatibility 
between Hf and B cells, it is further enhanced if Hf is incompatible with both A cells 
and B cells. The parameters that affect this interaction are currently being analyzed; 
nevertheless, the data suggest that Hf-B cell interaction might involve events that are 
more complex than merely the binding of Hf to the B cell. The involvement of A cells 
at the level of MHC-controlled T-B cell cooperation is also borne out in other in vivo 
work from this laboratory (46). 
In  conclusion,  we  demonstrate  that  the  proliferative  and  differentiative  signals 
required for B cell triggering can readily be dissected. Antigen alone induces neither 
B cell proliferation nor differentiation into AFC. B cell proliferation is induced in the 
presence  of Hf and  antigen,  but  the  reconstitution  of a  fully  differentiated  AFC 
response requires the additional presence of A cells or their secreted products. In the 
light of this and of our previous work, we would propose a  tentative model for the 
events leading to antigen-specific B cell triggering as follows: antigen-primed helper 
T  cells elaborate various factors, one of which  is  Hf, an antigen-specific Ia-bearing 
factor with a  minimum 50,000 mol wt (5). This factor is specific, both in terms of its 
binding  to  antigen,  and  in  terms of its  functional  activity  in  inducing  a  humoral 
response (2-5). Focused by its antigen-specific receptor to the antigen-binding B cell, 
Hf interacts in an H-2-restricted fashion with the cell surface membrane to induce the 
cell to proliferate. The mechanism of interaction between Hf and the B cell surface is 
unknown, but its control by the MHC raises the possibility that the I-A determinants 
found  on  Hf might  be critically  involved;  whether  or  not  the  proliferative  signal 
requires  that  Hf interact  simultaneously with  the  Ig receptor-antigen complex and 
with other determinants on the cell surface membrane has not yet been determined. 
Differentiation into an IgM-secreting cell does not occur unless additional,  nonanti- 
gen-specific signals are given by A cells. These A cells secrete soluble products, which, 
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the absence of Hf, B cells, even those that  have bound antigen,  are not receptive  to 
this differentiative signal. The signal originates from a  radioresistant  cell population 
that  includes  Thy-l.2-bearing cells;  the  contribution  of Thy-l.2-negative  A  ceils  in 
this  process is not yet defined.  IL-2 cannot  by itself substitute  for the differentiative 
signal  in  the  Hf-mediated  B  cell  response;  if it  is  involved,  it  cannot  be  the  only 
nonspecific signal required. The participation of A cells in the collaborative interaction 
with  Hf and B  cells  also appears  to be under MHC  control but  the  precise cellular 
and molecular mechanisms by which this is done remain to be elucidated. 
Summary 
Proliferative  and  differentiative  signals  controlling  the  in  vitro  IgM response  by 
unprimed, affinity-enriched B cells were studied using conditions under which as few 
as 2,000 B cells stimulated by antigen-specific, Ia-positive, allogeneically restricted, T 
cell-derived  helper  factor  (HI') or the polyclonal activator lipopolysaccharide  (LPS) 
yielded  on  the  average  400  antibody-forming cells  (AFC)  by  direct  plaque  assay. 
Antigen  alone  induces  neither  B  cell  proliferation  nor  differentiation  into  AFC. 
Proliferation  but  not  differentiation  into  AFC  is  induced  when  affinity-enriched  B 
cells  are  cultured  in  the  presence  of Ag  and  Hf  or  LPS  but  in  the  absence  of 
nonantigen-specific, radioresistant, accessory (A) cells. For the induction of a complete 
HI'- or LPS-mediated AFC response, cultures must be reconstituted with A cells or the 
secretory product(s)  of these cells.  The antigen-specific  response depends  strictly  on 
the  presence  of the  Hf specific  for the  relevant  antigen,  regardless  of the  cell  cycle 
state of cooperating B cells.  The differentiative signal  from A  cells is due, at  least  in 
part, to the presence of a Thy- 1.2-bearing population of cells. In the case of the LPS- 
mediated,  but  not  the  Hf-mediated  response,  A  cells  can  be  substituted  by  using 
supernatant  derived  from an interleukin  2-secreting T  lymphoma cell line  (EL4).  In 
the  presence  of histocompatible  Hf and  B  cells,  histoincompatible  A  cells  can  still 
cooperate  in  the  immune  response.  However,  the  degree  of allogeneic  restriction 
between incompatible Hf and B cells is markedly increased if both B cells and A cells 
are incompatible with HI'. 
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